See also: Immune Reconstitution Inflammatory Syndrome (IRIS)
Selected Fact Sheets and Recent Articles
- Why Inflammation Is a Hot Topic. Basic background information about inflammation from Berkeley Wellness. Although this article does not focus specifically on inflammation and HIV, it provides a good overview of inflammation, its functions, and the role of chronic inflammation in some diseases.
- Physical Activity by HIV Group Tied to Heart Markers and Inflammation. (September 2016, TheBodyPro)
- CAD in men with HIV linked to inflammatory biomarkers. (August 2016, Healio)
- Statin decreases arterial inflammation, immune activation in patients with HIV. (July 2016, Healio)
- Newly initiated ART does not reduce arterial inflammation in HIV patients. (June 2016, Healio)
- Breaking a “Vicious Circle”: Controlling HIV Reservoirs by Targeting Inflammation. (April 2016, amfAR)
- Hand OA [osteoarthritis] More Prevalent With HIV Infection – Metabolic syndrome further adds to hand OA risk (April 2016, MedPage Today)
- What Is Chronic Inflammation and Why Is It Such a Big Deal for People with HIV? (April 2016, Hepmag)
- Bodyweight influences risk for inflammation, mortality among HIV patients starting ART. (April 2016, Healio)
- Inflammation Markers Tied to Worse Kidney Function in Men Taking Antiretroviral Therapy. (October 2015, TheBodyPro)
- Weight Gain Exacerbates Inflammation in People Living with HIV. (October 2015, Beta Blog)
- Fat Tissue May Be Another Part of HIV Reservoir. (September 2015, Poz)
- The Low-Down on Inflammation from an HIV Doctor. (August 2015, Beta Blog)
- Inflammation and gut leakage remains elevated in people with HIV despite early antiretroviral treatment. (March 2015, AIDSmap)
- Inflammation Persists Despite Very Early HIV Treatment. (February 2015, TheBodyPro)
- Gum Disease Can Lead Dormant HIV to Replicate. (January 2015, Poz)
- Inflammation May Lead to Diabetes in People on HIV Meds. (October 2014, Poz)
- Inflammatory markers associated with development of diabetes in people taking HIV therapy. (October 2014, AIDSmap)
- Rosuvastatin may be partially effective in moderating residual immune activation on ART. (September/October 2014, HIV Treatment Bulletin)
- Inflammation/Activation Markers Drop With ATV, DRV, RAL, But Not Completely – ACTG Study. (July 2014, NATAP)
- Treating HIV Very Early May Limit Inflammation, Gut Damage. (April 2014, Poz)
- Arterial Inflammation Tied to High-Risk Coronary Plaques in HIV Group. (March 2014, NATAP)
- Brain Markers of Inflammation Drop to Normal With Early ART. (March 2014, NATAP)
- Fighting the fire [inflammation]. (Winter 2014, Positively Aware)
- New Piece of the Inflammation Puzzle Uncovered; CD4 Pyroptosis Mechanism Described. (December 2013, Project Inform)
- HIV-positive people not on antiretrovirals are prone to inflammation-related bone loss. (October 2013, AIDSmap)
- Liver fibrosis linked to immune activation in HIV/HCV co-infected women. (October 2013, AIDSmap)
- Gut Bacteria May Cause Inflammation, Aggravate HIV Disease. (July 2013, Poz)
- Statins Take Bite Out of Cancer Risk in People With HIV. (July 2013, Poz)
- Complications of HIV and its treatment, Impressions from the 20th CROI. (March 2013, NATAP)
- Inflammation and HIV at CROI 2013. (March 2013, NATAP)
- Cardiovascular Disease and Co-morbidities in HIV. (March 2013, NATAP)
- Antiretrovials Reduce Cellular Inflammation Among Elite Controllers of HIV. (March 2013, Poz)
- Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study. (March 2013, NATAP)
- Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect. (March 2013, AIDSmap)
- Cardiovascular Disease Risk Remains High in HIV Elite Controllers. (October 2012, Poz)
- Thalidomide for HIV-Related IRIS Shows Promise. (September 2012, Poz)
- Low levels of innate immune activation and high levels of gut antibodies may protect people from HIV. (August 2012, AIDSmap)
- Might Aspirin Reduce Cardiovascular Risk in People With HIV? (August 2012, Poz)
- Untreated HIV infection is associated with higher blood alcohol levels. (April 2012, AIDSmap)
- Low HIV viral load doesn’t cause inflammation or increase the risk of death. (November 2011, AIDSmap)
- Long-Term Tenofovir for Chronic Hepatitis B Reduces Liver Inflammation and Cirrhosis. (November 2011, HIVandhepatitis)
- Low Levels of HIV in the Blood Aren’t Connected to Inflammation or Death. (November 2011, Poz)
- Treatment with statins reduces mortality risk for patients taking effective HIV therapy. (August 2011, AIDSmap)